← Back to patent-cliff list
盐酸多奈哌齐
Tier C — Watch / tradeDonepezil Hydrochloride
卫材株式会社
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：AChE
Brand：安理申、Eranz、Aricept D、ADLARITY、Memac、Aricept Evess、Aricept、Memorit、Aricept ODT
Indications (approved)：路易氏体型失智症、阿尔茨海默病、痴呆
Regional status
US
批准上市
1996-11-25
EU
批准上市
2009-12-22
China
批准上市
2001-01-01
Japan
批准上市
1999-10-08
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Donepezil Hydrochloride?
Approved indications include: 路易氏体型失智症, 阿尔茨海默病, 痴呆.
When does the Donepezil Hydrochloride patent expire?
No public expiry year is available for Donepezil Hydrochloride yet; this page updates once verified.
How do I get a quote for Donepezil Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25